Physician profile
Salvatore Tarantino
NPI 1174581458
$6,231.01
in general payments reported to CMS, 2019-2025
42 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,295 · 2020: $1,201 · 2021: $1,170 · 2022: $874 · 2023: $632 · 2024: $599 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,691.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $817.31 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $714.75 | 2019-2025 | Jardiance, Tradjenta |
| Novo Nordisk INC | $579.54 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $552.49 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $527.82 | 2019-2025 | |
| Abbvie INC. | $363.60 | 2019-2025 | Qulipta |
| Allergan, INC. | $229.96 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $186.24 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $170.56 | 2019-2022 | |
| Amgen INC. | $164.32 | 2019-2024 | Evenity, Prolia, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $140.23 | 2019-2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $139.68 | 2019-2022 | |
| Amarin Pharma, INC. | $134.23 | 2019-2021 | |
| Daiichi Sankyo INC. | $131.29 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $121.13 | 2019-2023 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salvatore Tarantino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.